Amylyx Pharmaceuticals (AMLX) Capital Expenditures (2021 - 2025)
Amylyx Pharmaceuticals (AMLX) posted Capital Expenditures of $86,000 for Q4 2025, up 330.0% from $20,000 a year earlier and up 258.3% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Capital Expenditures (2021 - 2025) Analysis & Trends
For FY2025, Amylyx Pharmaceuticals' Capital Expenditures came in at $138,000, down 12.1% from FY2024.
- Annual Capital Expenditures has declined for three consecutive years, with a four-year compound annual growth rate of -20.9% (FY2021 to FY2025).
- In prior years, Amylyx Pharmaceuticals' Capital Expenditures was $157,000 in FY2024 (-87.3%), $1.24 million in FY2023 (-50.9%), $2.53 million in FY2022 (+615.6%) and $353,000 in FY2021.
- The Q4 2025 figure stands as the highest quarterly Capital Expenditures since Q2 2024.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last six quarters, with an average decline of 11.7%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q4 2025, with growth of 330.0%; the weakest was Q4 2024, with a decline of 94.4%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $24,000 (Q3 2025), $17,000 (Q2 2025) and $11,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Dec 31, 2023 | 356,000.00 |
| Sep 30, 2023 | 357,000.00 |
| Jun 30, 2023 | 278,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 620,000.00 |
| Sep 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 342,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 153,000.00 |
| Mar 31, 2021 | 14,000.00 |
API Access
Amylyx Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();